Type I and III collagen protein precursors and mRNA in the developing human lung

Journal of Pathology

Volumn 203, Issue 1, 2004, Pages 567-574

  Kaarteenaho Wiik, Riitta ^a   Pääkkö, Paavo ^a   Herva, Riitta ^a   Risteli, Juha ^a,b   Soini, Ylermi ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bronchopulmonary dysplasia; Collagen types I and III; Lung development; mRNA; Respiratory distress syndrome

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DESMIN; MESSENGER RNA; PROCOLLAGEN; SCLEROPROTEIN; VIMENTIN;

ARTICLE; AUTOPSY; BRONCHIOLE; BRONCHUS; CARTILAGE CELL; CELL TYPE; CONTROLLED STUDY; FIBROGENESIS; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INFANT; LUNG ALVEOLUS WALL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG PARENCHYMA; MYOFIBROBLAST; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DISEASE; ONTOGENY; PLEURA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY ARTERY; PULMONARY VEIN;

ACTINS; BRONCHOPULMONARY DYSPLASIA; COLLAGEN TYPE I; COLLAGEN TYPE III; DESMIN; EPITHELIUM; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT, NEWBORN; LUNG; PROTEIN PRECURSORS; PULMONARY ALVEOLI; PULMONARY ARTERY; PULMONARY VEINS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RNA, MESSENGER; VIMENTIN;

EID: 1942499760     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1547     Document Type: Article

References (35)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 27: 357-368.
2. DeLemos RA, Coalson JJ. The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 521-539.
3. Hack M, Horbar JD, Malloy MH, Tyson JE, Wright E, Wright L. Very low birth weight outcomes of the National Institute of Child Health and Human Developmental Neonatal Network. Pediatrics 1991; 87: 587-597.
4. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991; 88: 6642-6646.
5. Toti P, Buonocore G, Tanganelli P, et al. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol 1997; 24: 22-28.
6. Torikata C, Villiger B, Kuhn C III, McDonald JA. Ultrastructural distribution of fibronectin in normal and fibrotic lung. Lab Invest 1985; 52: 399-408.
7. Sinkin RA, Roberts M, LoMonaco MB, Sanders RJ, Metlay LA. Fibronectin expression in bronchopulmonary dysplasia. Pediatr Dev Pathol 1998; 1: 494-502.
8. Kaarteenaho-Wiik R, Kinnula VL, Herva R, Pääkkö P, Pöllänen R, Soini Y. Distribution and mRNA expression of tenascin-C in developing human lung. Am J Respir Cell Mol Biol 2001; 25: 341-346.
9. Kaarteenaho-Wiik R, Kinnula VL, Herva R, Soini Y, Pöllänen R, Pääkkö P. Tenascin-C is highly expressed in respiratory distress syndrome and bronchopulmonary dysplasia. J Histochem Cytochem 2002; 50: 423-431.
10. Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Pääkkö P. Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med 1996; 154: 511-518.
11. Kaminski N, Allard JD, Pittet JF, et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A 2000; 95: 15623-15628.
12. Thibeault DW, Mabry SM, Ekekezie II, Zhang X, Truog WE. Collagen scaffolding during development and its deformation with chronic lung disease. Pediatrics 2003; 111: 766-776.
13. Jobe AH, Bancalari E. NICHD/NHLBI/ORD Workshop Summary. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
14. Northway WH Jr. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 1992; 89: 969-973.
15. Rosan CR. Hyaline membrane disease and a related spectrum of neonatal pneumopathies. In Perspectives in Pediatric Pathology, Rosenberg HS, Bolande RP (eds). Yearbook Medical Publishers: Chicago, 1975; 16-60.
16. Hussain NA, Siddiqui NH, Stocker JR. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
17. Walker E, McNicol AM. In situ hybridization demonstrates the stability of mRNA in post-mortem rat tissues. J Pathol 1992; 168: 67-73.
18. Risteli J, Niemi S, Trivedi P, Mäentausta O, Moway AP, Risteli L. Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715-718.
19. Melkko J, Kauppila S, Niemi S, et al. Immunoassay for the intact aminoterminal propeptide of human type I procollagen (PINP). Clin Chem 1996; 42: 947-954.
20. Rosenfeld MA, Siegfried W, Yoshimura K, et al. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
21. Vuorio T, Mäkelä JK, Kähäri V-M, Vuorio E. Coordinated regulation of type I and type III collagen production and mRNA levels of proα1(I) and of proα2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res 1987; 279: 154-160.
22. Mäkelä JK, Raassina M, Virta A, Vuorio E. Human proα(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acid Res 1988; 16: 349.
23. Pääkkö P, Nuorva K, Kamel D, Soini Y. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Am J Respir Cell Mol Biol 1992; 7: 325-334.
24. Kuhn C, McDonald JA. The roles of the myofibroblasts in the idiopathic pulmonary fibrosis. Am J Pathol 1991; 138: 1257-1265.
25. McGowan S. Extracellular matrix and the regulation of lung development and repair. FASEB J 1991; 6: 2895-2904.
26. Miyahara M, Njieha FK, Prockop DJ. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. J Biol Chem 1982; 257: 8442-8448.
27. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995; 22: 77-81.
28. Kratchowil K, Dziadek M, Lohler J, Harbers K, Jaenish R. Normal branching morphogenesis in the absence of collagen I. Dev Biol 1986; 117: 596-606.
29. Cherukupalli K, Larson JE, Rotschild A, Thurlbeck WM. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 22: 215-229.
30. Shoemaker CT, Reiser KM, Goetzman BW, Last JA. Elevated ratios of type I/III collagen in the lungs of chronically ventilated neonates with respiratory distress. Pediatr Res 1984; 18: 1176-1180.
31. McAnulty RJ, Campa JS, Cambrey AD, Laurent GJ. The effect of growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta 1991; 31: 231-235.
32. Sakai T, Kawakatsu H, Ohta M, Saito M. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-β in vitro. J Cell Phys 1994; 159: 561-572.
33. Serini G, Gabbiani G. Minireview. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999; 250: 273-283.
34. Ohta K, Mortenson RL, Clark RA, Hirose N, King TE. Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152: 1659-1665.
35. Pääkkö P, Kaarteenaho-Wiik R, Pöllänen R, Soini Y. Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia. Am J Respir Crit Care Med 2000; 161: 967-972.